Philipp Karbach is the founder of Arzneimittelwerk Warngau. Latest round: Series A. Backed by Ren Life Sciences, Juno Capital Partners, SHS Capital.
Philipp Karbach is the CEO and shareholder of AMW GmbH, a specialty biopharmaceutical company based in Warngau, Germany. AMW focuses on biodegradable sustained-release drug delivery systems, offering value-added medicines and cost-effective therapies, with two approved products, goserelin and leuprorelin implants, distributed globally. In early 2024, Karbach's AMW Beteiligungsgesellschaft mbH & Co KG acquired 23.66% of AMW's shares, and he also initiated the "AMW Evolution program" to allow employees to become shareholders.
Full founder directory · Investor directory · Company funding database · Fundraising library